Normal
Could be a good buying opportunity for SIG.I feel that the termination of the supply agreement with Chemist Warehouse may have already been priced in as this should not be a surprise to any shareholder this was advised in May 2017 and since they started legal proceedings it was very clear that there was no coming back to repair the relationship with CW.The drop in price may have been an overreaction for the CW announcement but more so to the profit downgrade from 90m to 75m EBIT for FY19, which was not really impacted by the CW deal as this supply agreement terminates at 30 June 2019 more so softer sales...I'll be watching this space.
Could be a good buying opportunity for SIG.
I feel that the termination of the supply agreement with Chemist Warehouse may have already been priced in as this should not be a surprise to any shareholder this was advised in May 2017 and since they started legal proceedings it was very clear that there was no coming back to repair the relationship with CW.
The drop in price may have been an overreaction for the CW announcement but more so to the profit downgrade from 90m to 75m EBIT for FY19, which was not really impacted by the CW deal as this supply agreement terminates at 30 June 2019 more so softer sales...
I'll be watching this space.
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.
